225 related articles for article (PubMed ID: 25896424)
1. Inhibition of STAT3 signaling as critical molecular event in resveratrol-suppressed ovarian cancer cells.
Zhong LX; Li H; Wu ML; Liu XY; Zhong MJ; Chen XY; Liu J; Zhang Y
J Ovarian Res; 2015 Apr; 8():25. PubMed ID: 25896424
[TBL] [Abstract][Full Text] [Related]
2. Correlation of ARHI upregulation with growth suppression and STAT3 inactivation in resveratrol-treated ovarian cancer cells.
Zhong LX; Nie JH; Liu J; Lin LZ
Cancer Biomark; 2018; 21(4):787-795. PubMed ID: 29504523
[TBL] [Abstract][Full Text] [Related]
3. Biological significance and therapeutic implication of resveratrol-inhibited Wnt, Notch and STAT3 signaling in cervical cancer cells.
Zhang P; Li H; Yang B; Yang F; Zhang LL; Kong QY; Chen XY; Wu ML; Liu J
Genes Cancer; 2014 May; 5(5-6):154-64. PubMed ID: 25061499
[TBL] [Abstract][Full Text] [Related]
4. PIAS3, SHP2 and SOCS3 Expression patterns in Cervical Cancers: Relevance with activation and resveratrol-caused inactivation of STAT3 signaling.
Zhang P; Yang B; Yao YY; Zhong LX; Chen XY; Kong QY; Wu ML; Li C; Li H; Liu J
Gynecol Oncol; 2015 Dec; 139(3):529-35. PubMed ID: 26432044
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol suppresses the STAT3 signaling pathway and inhibits proliferation of high glucose-exposed HepG2 cells partly through SIRT1.
Li Y; Zhu W; Li J; Liu M; Wei M
Oncol Rep; 2013 Dec; 30(6):2820-8. PubMed ID: 24064760
[TBL] [Abstract][Full Text] [Related]
6. SHP2, SOCS3 and PIAS3 Expression Patterns in Medulloblastomas: Relevance to STAT3 Activation and Resveratrol-Suppressed STAT3 Signaling.
Li C; Li H; Zhang P; Yu LJ; Huang TM; Song X; Kong QY; Dong JL; Li PN; Liu J
Nutrients; 2016 Dec; 9(1):. PubMed ID: 28035977
[TBL] [Abstract][Full Text] [Related]
7. Pterostilbene exerts antitumor activity against human osteosarcoma cells by inhibiting the JAK2/STAT3 signaling pathway.
Liu Y; Wang L; Wu Y; Lv C; Li X; Cao X; Yang M; Feng D; Luo Z
Toxicology; 2013 Feb; 304():120-31. PubMed ID: 23313376
[TBL] [Abstract][Full Text] [Related]
8. STAT3 signaling statuses determine the fate of resveratrol-treated anaplastic thyroid cancer cells.
Wu J; Li YT; Tian XT; Liu YS; Wu ML; Li PN; Liu J
Cancer Biomark; 2020; 27(4):461-469. PubMed ID: 31958078
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol and STAT inhibitor enhance autophagy in ovarian cancer cells.
Zhong LX; Zhang Y; Wu ML; Liu YN; Zhang P; Chen XY; Kong QY; Liu J; Li H
Cell Death Discov; 2016; 2():15071. PubMed ID: 27551495
[TBL] [Abstract][Full Text] [Related]
10. Pterostilbene Suppresses Ovarian Cancer Growth via Induction of Apoptosis and Blockade of Cell Cycle Progression Involving Inhibition of the STAT3 Pathway.
Wen W; Lowe G; Roberts CM; Finlay J; Han ES; Glackin CA; Dellinger TH
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986501
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of STAT3 expression and signaling in resveratrol-differentiated medulloblastoma cells.
Yu LJ; Wu ML; Li H; Chen XY; Wang Q; Sun Y; Kong QY; Liu J
Neoplasia; 2008 Jul; 10(7):736-44. PubMed ID: 18592012
[TBL] [Abstract][Full Text] [Related]
12. GRIM‑19‑mediated Stat3 activation is a determinant for resveratrol‑induced proliferation and cytotoxicity in cervical tumor‑derived cell lines.
Li YG; Xia HJ; Tao JP; Xin P; Liu MY; Li JB; Zhu W; Wei M
Mol Med Rep; 2015 Feb; 11(2):1272-7. PubMed ID: 25351437
[TBL] [Abstract][Full Text] [Related]
13. Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancer.
Wen W; Wu J; Liu L; Tian Y; Buettner R; Hsieh MY; Horne D; Dellinger TH; Han ES; Jove R; Yim JH
Mol Cancer; 2015 May; 14():100. PubMed ID: 25928246
[TBL] [Abstract][Full Text] [Related]
14. Discovery of oral-available resveratrol-caffeic acid based hybrids inhibiting acetylated and phosphorylated STAT3 protein.
Li S; Zhang W; Yang Y; Ma T; Guo J; Wang S; Yu W; Kong L
Eur J Med Chem; 2016 Nov; 124():1006-1018. PubMed ID: 27783972
[TBL] [Abstract][Full Text] [Related]
15. ESC-3 induces apoptosis of human ovarian carcinomas through Wnt/β-catenin and Notch signaling in vitro and in vivo.
Fu QR; Song W; Deng YT; Li HL; Mao XM; Lin CL; Zheng YH; Chen SM; Chen QH; Chen QX
Int J Oncol; 2017 Jan; 50(1):241-251. PubMed ID: 27878242
[TBL] [Abstract][Full Text] [Related]
16. Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer.
Duan Z; Foster R; Bell DA; Mahoney J; Wolak K; Vaidya A; Hampel C; Lee H; Seiden MV
Clin Cancer Res; 2006 Sep; 12(17):5055-63. PubMed ID: 16951221
[TBL] [Abstract][Full Text] [Related]
17. The STAT3-miRNA-92-Wnt Signaling Pathway Regulates Spheroid Formation and Malignant Progression in Ovarian Cancer.
Chen MW; Yang ST; Chien MH; Hua KT; Wu CJ; Hsiao SM; Lin H; Hsiao M; Su JL; Wei LH
Cancer Res; 2017 Apr; 77(8):1955-1967. PubMed ID: 28209618
[TBL] [Abstract][Full Text] [Related]
18. Targeting STAT3 by HO3867 induces apoptosis in ovarian clear cell carcinoma.
Bixel K; Saini U; Kumar Bid H; Fowler J; Riley M; Wanner R; Deepa Priya Dorayappan K; Rajendran S; Konishi I; Matsumura N; Cohn DE; Selvendiran K
Int J Cancer; 2017 Nov; 141(9):1856-1866. PubMed ID: 28646535
[TBL] [Abstract][Full Text] [Related]
19. Lumbar puncture-administered resveratrol inhibits STAT3 activation, enhancing autophagy and apoptosis in orthotopic rat glioblastomas.
Xue S; Xiao-Hong S; Lin S; Jie B; Li-Li W; Jia-Yao G; Shun S; Pei-Nan L; Mo-Li W; Qian W; Xiao-Yan C; Qing-You K; Peng Z; Hong L; Jia L
Oncotarget; 2016 Nov; 7(46):75790-75799. PubMed ID: 27716625
[TBL] [Abstract][Full Text] [Related]
20. The molecular mechanism of action of superactive human leptin antagonist (SHLA) and quadruple leptin mutein Lan-2 on human ovarian epithelial cell lines.
Fiedor E; Gregoraszczuk EŁ
Cancer Chemother Pharmacol; 2016 Sep; 78(3):611-22. PubMed ID: 27480179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
